
âAustralia is a place that can actually change the world in mental health, provided we get the right government support to do so.â â Patrick McGorry
By CCHR International
June 16, 2010
A Public Service Announcement on Australian TV features Australian of the Year, psychiatrist Patrick McGorry, claiming that nearly half the population will experience mental ill-health during their lifetime. Considering that after World War II, psychiatrists claimed that one in 20 people had a mental disorder, and now itâs every second one of us, thatâs a damning 1000 percent failure rate for psychiatrists in reducing “mental illness.â Let’s get real; the reason psychiatrists claim more people are mentally ill is because they can keep inventing new ways to label them mentally illâbut the press and governments are starting to catch on, evidenced by all the controversy surrounding psychiatry’s upcoming edition of their Diagnostic and Statistical Manual of Mental Disorders (DSM)âbetter known as psychiatry’s billing bible. Yet of all the proposed “mental disorders” ranging from overeating to kids throwing tantrums, no proposed model of mental disorder is more insidious and dangerous than that of Patrick McGorry, who promotes diagnosing people before they develop a so-called mental disorderâdrugging them before they become “mentally ill.” Yet the Australian government has bought into it hook, line and sinkerâdespite the fact McGorry’s plan is so outrageous, even his peers, such as psychiatrist Allen Frances, former Chair of the DSM task force, have called it ”the most ill-conceived and potentially harmful.â
Make no mistake, the pre-drugging agenda is Patrick McGorryâs babyâhis dream for a new paradigm in mental health, one that has the power to diagnose and drug people before they become mentally illâwelcome to the Brave New World of Patrick McGorry. And he isn’t stopping with Australia; his plan is to go global. As he recently stated, âAustralia is a place that can actually change the world in mental health, provided we get the right government support to do so.â[1]
The fact that McGorryâs agenda is so controversialâit even has other psychiatrists protesting itâhas not deterred the Australian government from funding this âill-conceivedâ plan. A recent letter to Citizens Commission on Human Rights states, âThe Australian Government is providing $25.5 million over four years from 2010-2011 to expand Early Psychosis Prevention and Intervention Centre (EPPIC) model,â developed by McGorry who founded EPPIC and the Orygen Youth Health in Victoria, Australia.
The Australian Government has already been criticized for massive expenditure on psychotropic drugs increasing more than 660 percent during the last decadeâwith a whopping 3,100 percent increase on antipsychotic drugs (with at least 15 Australian deaths in the under 19 year olds as a tragic consequence of this). This can only get worse when under McGorryâs plan, with an enormous client base that can be prescribed drugs despite the fact they are not yet “mentally ill.” Itâs called prodrome (prodromos meaning the forerunner of an event)âreferring to âa period of prepsychotic disturbanceâ that may or may not develop into psychosis or âschizophreniaâ[2]âin other words, the crystal ball theory.
Australia Meets the US in Pre-Drug Scam
McGorryâs plan for Australia to âlead the changeâ in world mental health is happeningâto the detriment of those who may be forced to undergo drug treatment based on a psychiatrist’s hunch that they might, one day, become ill. In the U.S., on May 13, 2009, the Department of Health and Human Services convened a Technical Expert Panel (TEP) discussed âemerging evidence around psychopharmacological interventions for first episode schizophreniaâ citing the research efforts of McGorry and others.[3]
The push for pre-diagnosing and pre-drugging has even those within the psychiatric profession calling foul; Dr. Richard Warner, professor of psychiatry at the University of Colorado, counters the idea that science drives McGorryâs pre-disorder assessment, stating, “Given the expected number of false positives, the potential for harm is significant.â[4]
However, as Anthony Pelosi, honorary professor, Department of Psychiatry, Hairmyres Hospital, wrote in a counter to McGorry in the British Medical Journal last year, âthis has not stopped their skillful lobbying of politicians, journalists, patients, and carers with upbeat messages about the prevention.â
“Skillful lobbying” is right.
In 2006 McGorry and other researchers, including psychiatrist Michael Berk, Karen Hallam, Craig McNeil, Linda Kaler and psychologist Melissa Hasty reported in the Medical Journal of Australia, âEvidence increasingly indicates that earlier identification may allow for appropriate pharmacological and psychosocial treatmentsâŠ.â[5]
Could they have a Pharma incentive behind this agenda? Berk is financially linked to AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Lundbeck, Organon, Novartis, Mayne Pharma, Servier, Sanofi-Synthelabo, Solvay, and Wyeth and Pfizer.[6] Hallam disclosed received speaker fees from Janssen-Cilag; McNeil received consultancy fees, speaker fees and travel assistance from Eli Lilly, Janssen-Cilag and Sanofi-Aventis; and Hasty and Linda received financial assistance to attend conferences from or Janssen-Cilag, maker of the antipsychotic Risperdal (resperidone).[7]
McGorry has received grant support from Eli Lilly, Janssen-Cilag, Bristol Myers Squibb, Astra-Zeneca, Pfizer, and Novartis.[8] He is a paid consultant for, and has received speakerâs fees from all or most of these companies.[9] Studies published in the British Medical Journal in 2005 and 2008 declared McGorryâs âearly intervention studies have received partial support in the form of investigator-initiated unrestricted research grants from Janssen-Cilag.â[10]
The U.S. has already begun adopting the âearly interventionâ fad, which looks more like a trade in childrenâs lives and a business opportunity for increased pharmaceutical sales. In March 2010, the Department of Health & Human Services Substance Abuse & Mental Health Service Administration Center for Mental Health Services announced $16.5 million in funding for âMental Health Transformation Grants,â including the âEarly Detection and Intervention for the Prevention of Psychosis Program (EDIPPP).â[11]
EDIPP is the American sister of McGorryâs EPPIC. It was originally bankrolled by a $14.4 million grant from the Robert Wood Johnson Foundation. According to investigative journalist Evelyn Pringle, âThe founder of RWJF, Robert Wood Johnson, was chairman of Johnson & Johnson for over 30 years, from 1932 to 1963, as a member of the drug makerâs founding family. Throughout the years, the majority of the Foundationâs money has come from investments in J&J stock.â
In an article in Behavioral Healthcare, in 2008, the Mid-Valley Behavioral Care Network (MVBCN), an intergovernmental Medicaid government insurance-managed healthcare organization situated in Oregon, was recommended to study EPPIC used at Orygen and EDIPPP.
Based on EDIPP and EPPIC, the MVBCN developed the Early Assessment and Support Team (EAST) in 2001. In 2003, the Oregon state legislature allocated $4.3 million to disseminate early psychosis intervention statewide. By March the following year, new programs had begun in 12 counties.[12]
EDIPPP also replicates the âPortland Identification and Early Referral,â or âPIER,â a treatment research program at the Main Medical Center, in Portland, Maine.[13] People typically are referred to PIER by high school guidance counselors, pediatricians, or other clinicians who attended presentations about PIERâs work, says Pringle. âVirtually every person entering the PIER program is prescribed antipsychotics, such as Risperdal or Invega, marketed by Johnson & Johnson,â she added.
Both PIER and EDIPPP are promoted in McGorryâs 2002 book, Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services.â[14] The bookâs foreword is written by Dr. Jeffrey Lieberman, Professor of Psychiatry, Chairman Department of Psychiatry, Columbia University College of Physicians and Surgeons.[15] Lieberman has taken consulting fees and research grant support from AstraZeneca, Bristol-Myers Squibb, Upjohn Pharmacia, Novartis, Eli Lilly, Janssen, Pfizer, Hoechst AG, & AstraZeneca. Heâs on the Speakers Bureaus for Astra Zeneca, Janssen, Eli Lilly and Pfizer.[16]
Lieberman is also the Vice President (North America) of the McGorry instigated group International Early Psychosis Association (IEPA), which was officially incorporated in Victoria in 1998.[17] McGorry is currently Treasurer of the Association.[18] Lieberman is a member of the psychiatric-pharmaceutical company front groups, National Alliance for the Mentally Ill (NAMI) and National Alliance for Research on Schizophrenia and Depression (NARSAD).
Between 1999 and 2003 IEPA received unrestricted education grants from Janssen-Cilag and AstraZeneca.[19] EIPAâs conferences are supported by Janssen-Cilag, AstraZeneca, Eli Lilly, and Bristol-Myers Squibb.[20]
The IEPA lists the âwhoâs whoâ of Pre-Psychosis Risk Syndrome (the official label given pre-psychotic symptoms) and many of its board or members disclose manufacturers of antipsychotics as companies theyâve received financing from.
On July 29-30, the First international Youth Mental Health Conference is being held in Melbourne, with keynote speakers, including McGorry. The conference is described by one advocate as an âimportant and innovative event, attracting the best in the business/industry to discuss the emerging issues of youth mental health.â[21]
It couldnât have been more adequately stated: business and industry. Herein you see McGorryâs pitch again that Australia is a global leader in this latest psychiatric fad. His invitation online states, âThis is an important event for Australia and the mental health field. We expect this to be the first of many similar conferences, bringing together innovators, practitioners, researchers, young people and families to showcase the best of youth mental health innovation from around the globe.â[22] [Emphasis added]
Thereâs no doubt that this conference, like his Australian award, will be used to demand more funding to increase the business stakes and drive more income into psychiatryâs pre-drugging efforts. Despite the government already allocating $103 million to McGorry, including the $25 million to further research EPPIC, he continues to call for another $800 million in funding for programs for youth mental health over the next four years.[23]
McGorry recently stated, âYou have to be able to give something of yourself to people, if you are going to help them.â[24] McGorry’s brand of “helping” entails stigmatizing children with psychiatric labels that have no basis in science or medicine and then drugging them. That does not qualify as “help.” It’s betrayal. If this agenda to pre-diagnose, and pre-drug is allowed to take hold, we will truly have entered a Brave New World; Patrick McGorry’s.
[1] http://sydney.edu.au/medicine/museum/mwmuseum/index.php/McGorry,_Patrick
[2] http://www.mentalhealth.com/mag1/scz/sb-prod.html
[3] U.S. Department of Health and Human Services, âASPE Technical Expert Panel on Earlier Intervention for Serious Mental Illness: Summary of Major Themes,â The Lewin Group, 13 May, 2009.
[4] Richard Warner, MB, DPM, is director of Colorado Recovery in Boulder, Colorado, and professor of psychiatry at the University of Colorado, âEarly intervention in psychosis: Future or fad?â Centre for Addiction and Mental Health website, http://www.camh.net/Publications/Cross_Currents/Winter_2007-08/futureorfad_crcuwinter0708.html.
[5] http://www.mja.com.au/public/issues/187_07_011007/ber10341_fm.pdf
[6] http://www.mja.com.au/public/issues/187_07_011007/ber10341_fm.pdf
[7] http://www.mja.com.au/public/issues/187_07_011007/ber10341_fm.pdf
[8] http://www.mhanet.ca/documents/2008/Research-Colloquium/0920%20-%20Keynote%20MCGORRY.pdf
[9] http://www.bmj.com/cgi/content/full/337/aug04_1/a695
[10] http://bjp.rcpsych.org/cgi/content/full/187/48/s108; http://www.bmj.com/cgi/content/full/337/aug04_1/a695
[11] http://www.opednews.com/articles/Tracking-the-American-Epid-by-Evelyn-Pringle-100602-668.html
[12] http://www.behavioral.net/ME2/dirmod.asp?sid=9B6FFC446FF7486981EA3C0C3CCE4943&nm=Archives&type=Publishing&mod=Publications%3A%3AArticle&mid=64D490AC6A7D4FE1AEB453627F1A4A32&id=BFCD36BFD75E447CA63F662A633F41FB&tier=4
[13] http://www.opednews.com/articles/Tracking-the-American-Epid-by-Evelyn-Pringle-100602-668.html
[14] http://books.google.com.au/books?id=lyLfMPsnvJ0C&pg=PA136&lpg=PA136&dq=Portland+Identification+and+Early+Referral+McGorry&source=bl&ots=lEp9tdT8ZV&sig=_zlnHeFk8oqxTHSjbvLf0XQmlY4&hl=en&ei=lP0RTKThLMWPcMnSzNAH&sa=X&oi=book_result&ct=result&resnum=1&ved=0CBQQ6AEwAA#v=onepage&q&f=false
[15] http://69.5.18.33/ahrp/cms/index2.php?option=com_content&do_pdf=1&id=345
[16] http://69.5.18.33/ahrp/cms/index2.php?option=com_content&do_pdf=1&id=345
[17] http://www.iepa.org.au/ContentPage.aspx?pageID=10
[18] http://www.headspace.org.au/about/headspace-board/
[19] http://www.iepa.org.au/ContentPage.aspx?pageID=59
[20] http://www.iepa.org.au/ContentPage.aspx?pageID=59
[21] http://www.iymhconference.com.au/why-attend/
[22] http://www.iymhconference.com.au/
[23] Mental Health Update, GetUp! Action for Australia, 21 Apr. 2010, http://www.getup.org.au/blogs/view.php?id=1936&dc=1086,21560,1
[24] http://sydney.edu.au/medicine/museum/mwmuseum/index.php/McGorry,_Patrick
RETURN TO BLOGS PAGE